Evidence map›Paper›PMID 41640697›Full record

ArticleScienceBank2025

Daniel Vasquez, David Aguillon, Paula Perez Corredor, Diana Paola Alzate Echeverri, Yesica Zuluaga, Ana Y Baena, Lucia Madrigal, Liliana Hincapié, Liliana Ramirez Gomez, Lusiana Martinez and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ScienceBank, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daniel VasquezGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
David AguillonGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Paula Perez CorredorSchepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School.
Diana Paola Alzate EcheverriGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Yesica ZuluagaGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Ana Y BaenaGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Lucia MadrigalGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Liliana HincapiéGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Liliana Ramirez GomezMassachusetts General Hospital, Harvard Medical School. Boston, MA, USA.
Lusiana MartinezMassachusetts General Hospital, Harvard Medical School. Boston, MA, USA.
Vincent MalotauxMassachusetts General Hospital, Harvard Medical School. Boston, MA, USA.
Francisco LoperaGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Yakeel T QuirozGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Joseph F Arboleda-VelasquezSchepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School.

Funding

Resilience to Cognitive Decline and Resistance to Alzheimer's Disease and Related Neurodegenerative Diseases in Individuals from Colombia with Autosomal Dominant DementiasRM1NS132996 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI AGUILLON, DAVID FERNANDO, ARBOLEDA-VELASQUEZ, JOSEPH · 2023 to 2023
$3.8M
NINDS NIH HHS RM1 NS132996
6 · The paper itself

Abstract

We previously identified

Indexed as

AgingApolipoprotein ECase seriesCentenariansGenetic Predisposition to DiseaseReelin

Identifiers

PMID41640697
PMCPMC12867035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.